272 related articles for article (PubMed ID: 17638888)
1. Genetic ablation of CCAAT/enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis.
Loomis KD; Zhu S; Yoon K; Johnson PF; Smart RC
Cancer Res; 2007 Jul; 67(14):6768-76. PubMed ID: 17638888
[TBL] [Abstract][Full Text] [Related]
2. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation.
Shim M; Powers KL; Ewing SJ; Zhu S; Smart RC
Cancer Res; 2005 Feb; 65(3):861-7. PubMed ID: 15705884
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
4. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
[TBL] [Abstract][Full Text] [Related]
5. C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades.
Shi YC; Zhao H; Yin C; Zeng X; Zhang Q; Xu WP; Wei J; Chen F; Xie WF
Dig Liver Dis; 2013 Oct; 45(10):844-51. PubMed ID: 23816696
[TBL] [Abstract][Full Text] [Related]
6. C/EBPalpha and beta couple interfollicular keratinocyte proliferation arrest to commitment and terminal differentiation.
Lopez RG; Garcia-Silva S; Moore SJ; Bereshchenko O; Martinez-Cruz AB; Ermakova O; Kurz E; Paramio JM; Nerlov C
Nat Cell Biol; 2009 Oct; 11(10):1181-90. PubMed ID: 19749746
[TBL] [Abstract][Full Text] [Related]
7. CCAAT/enhancer-binding protein-α suppresses lung tumor development in mice through the p38α MAP kinase pathway.
Sato A; Yamada N; Ogawa Y; Ikegami M
PLoS One; 2013; 8(2):e57013. PubMed ID: 23437297
[TBL] [Abstract][Full Text] [Related]
8. A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm.
Togami K; Kitaura J; Uchida T; Inoue D; Nishimura K; Kawabata KC; Nagase R; Horikawa S; Izawa K; Fukuyama T; Nakahara F; Oki T; Harada Y; Harada H; Aburatani H; Kitamura T
Exp Hematol; 2015 Apr; 43(4):300-8.e1. PubMed ID: 25534203
[TBL] [Abstract][Full Text] [Related]
9. C/EBPalpha is a DNA damage-inducible p53-regulated mediator of the G1 checkpoint in keratinocytes.
Yoon K; Smart RC
Mol Cell Biol; 2004 Dec; 24(24):10650-60. PubMed ID: 15572670
[TBL] [Abstract][Full Text] [Related]
10. C/EBPalpha and C/EBPbeta are required for Sebocyte differentiation and stratified squamous differentiation in adult mouse skin.
House JS; Zhu S; Ranjan R; Linder K; Smart RC
PLoS One; 2010 Mar; 5(3):e9837. PubMed ID: 20352127
[TBL] [Abstract][Full Text] [Related]
11. Expression of CCAAT/enhancer binding proteins (C/EBP) is associated with squamous differentiation in epidermis and isolated primary keratinocytes and is altered in skin neoplasms.
Oh HS; Smart RC
J Invest Dermatol; 1998 Jun; 110(6):939-45. PubMed ID: 9620302
[TBL] [Abstract][Full Text] [Related]
12. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction.
Rangatia J; Vangala RK; Singh SM; Peer Zada AA; Elsässer A; Kohlmann A; Haferlach T; Tenen DG; Hiddemann W; Behre G
Oncogene; 2003 Jul; 22(30):4760-4. PubMed ID: 12879022
[TBL] [Abstract][Full Text] [Related]
13. C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia.
Hughes JM; Legnini I; Salvatori B; Masciarelli S; Marchioni M; Fazi F; Morlando M; Bozzoni I; Fatica A
Oncotarget; 2015 Jul; 6(21):18534-44. PubMed ID: 26053097
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias.
Gombart AF; Hofmann WK; Kawano S; Takeuchi S; Krug U; Kwok SH; Larsen RJ; Asou H; Miller CW; Hoelzer D; Koeffler HP
Blood; 2002 Feb; 99(4):1332-40. PubMed ID: 11830484
[TBL] [Abstract][Full Text] [Related]
15. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.
Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP
Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation and antiproliferative role of C/EBPalpha in lung cancer.
Halmos B; Huettner CS; Kocher O; Ferenczi K; Karp DD; Tenen DG
Cancer Res; 2002 Jan; 62(2):528-34. PubMed ID: 11809705
[TBL] [Abstract][Full Text] [Related]
17. CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling.
Zhu S; Yoon K; Sterneck E; Johnson PF; Smart RC
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):207-12. PubMed ID: 11756662
[TBL] [Abstract][Full Text] [Related]
18. Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models.
Kato N; Kitaura J; Doki N; Komeno Y; Watanabe-Okochi N; Togami K; Nakahara F; Oki T; Enomoto Y; Fukuchi Y; Nakajima H; Harada Y; Harada H; Kitamura T
Blood; 2011 Jan; 117(1):221-33. PubMed ID: 20884804
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
Bennett KL; Hackanson B; Smith LT; Morrison CD; Lang JC; Schuller DE; Weber F; Eng C; Plass C
Cancer Res; 2007 May; 67(10):4657-64. PubMed ID: 17510391
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]